Sat, Aug 30, 2014, 11:41 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sequenom Inc. Message Board

  • mastino88 mastino88 Jun 12, 2013 7:00 AM Flag

    SQNM NC opened already !!!!!!


    HH delivering early once again

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Opening a good thing

    • This announcement didn't just announce the opening, it announced that it "is now processing patient samples commercially". It seems obvious that this facility has taken the first step to generating revenue to support itself. This should also help maintain turn-around time for tests, and as a result keep SQNM on top. This was not an announcement that a building opened, it annouced active additional production. What this facility also provides is significant capacity growth and lab space for additional tests in the development pipeline.

      Sentiment: Strong Buy

    • Sequenom CMM Opens New CLIA Lab Facility In North Carolina

      SAN DIEGO, June 12, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed the build-out and validation of an additional laboratory location in Raleigh-Durham, NC, and is now processing patient samples commercially. This new laboratory location adds capacity and redundancy to the existing Sequenom CMM laboratory locations in California and Michigan.

      With an initial capacity of 100,000 tests per year, the North Carolina facility will primarily support processing of the MaterniT21 PLUS laboratory-developed test (LDT) and will immediately increase Sequenom CMM's total MaterniT21 PLUS testing capacity to over 300,000 test samples per year. This practice-changing prenatal LDT analyzes the relative amount of chromosome 21, 18, and 13, as well as X and Y material in cell-free fetal DNA obtained from a maternal blood sample as early as 10 weeks of pregnancy.

      "We are excited about the opening in North Carolina of our third US-based laboratory location. Our investment in establishing this new presence on the East coast will allow us to better meet the needs of health care providers by providing critical additional capacity and geographic back-up needed to address the rapidly growing adoption of our testing services," said William Welch, President and COO, Sequenom, Inc.

      The new laboratory location received its Clinical Laboratory Improvement Amendments (CLIA) registration for operation in May of 2013.

      The MaterniT21 PLUS LDT is intended for use in pregnant women at increased risk for fetal aneuploidy. Estimates suggest there are about 750,000 pregnancies at high risk for fetal aneuploidy each year in the United States. The MaterniT21 PLUS test is available exclusively through the Sequenom CMM as a testing service provide

      Sentiment: Strong Buy

    • Let's Rock and Roll!

3.71-0.10(-2.62%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Burger King Worldwide, Inc.
NYSEFri, Aug 29, 2014 4:02 PM EDT
Synaptics Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT